Cargando…

Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins

BACKGROUND: Little is known about patients with cancer presenting with acute chest discomfort to the emergency department (ED). OBJECTIVES: The aim of this study was to assess the prevalence of acute myocardial infarction (AMI), outcomes, and the diagnostic utility of recommended diagnostic tools in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bima, Paolo, Lopez-Ayala, Pedro, Koechlin, Luca, Boeddinghaus, Jasper, Nestelberger, Thomas, Okamura, Bernhard, Muench-Gerber, Tamar S., Sanzone, Alessandra, Skolozubova, Daria, Djurdjevic, David, Rubini Gimenez, Maria, Wildi, Karin, Miro, Oscar, Martínez-Nadal, Gemma, Martin-Sanchez, Francisco J., Christ, Michael, Keller, Dagmar, Lindahl, Bertil, Giannitsis, Evangelos, Mueller, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635894/
https://www.ncbi.nlm.nih.gov/pubmed/37969646
http://dx.doi.org/10.1016/j.jaccao.2023.08.001
_version_ 1785146382773911552
author Bima, Paolo
Lopez-Ayala, Pedro
Koechlin, Luca
Boeddinghaus, Jasper
Nestelberger, Thomas
Okamura, Bernhard
Muench-Gerber, Tamar S.
Sanzone, Alessandra
Skolozubova, Daria
Djurdjevic, David
Rubini Gimenez, Maria
Wildi, Karin
Miro, Oscar
Martínez-Nadal, Gemma
Martin-Sanchez, Francisco J.
Christ, Michael
Keller, Dagmar
Lindahl, Bertil
Giannitsis, Evangelos
Mueller, Christian
author_facet Bima, Paolo
Lopez-Ayala, Pedro
Koechlin, Luca
Boeddinghaus, Jasper
Nestelberger, Thomas
Okamura, Bernhard
Muench-Gerber, Tamar S.
Sanzone, Alessandra
Skolozubova, Daria
Djurdjevic, David
Rubini Gimenez, Maria
Wildi, Karin
Miro, Oscar
Martínez-Nadal, Gemma
Martin-Sanchez, Francisco J.
Christ, Michael
Keller, Dagmar
Lindahl, Bertil
Giannitsis, Evangelos
Mueller, Christian
author_sort Bima, Paolo
collection PubMed
description BACKGROUND: Little is known about patients with cancer presenting with acute chest discomfort to the emergency department (ED). OBJECTIVES: The aim of this study was to assess the prevalence of acute myocardial infarction (AMI), outcomes, and the diagnostic utility of recommended diagnostic tools in this population. METHODS: Patients presenting with chest pain to the ED were prospectively enrolled in an international multicenter diagnostic study with central adjudication. Cancer status was assessed prospectively and additional cancer details retrospectively. Findings were externally validated in an independent multicenter cohort. RESULTS: Among 8,267 patients, 711 (8.6%) had cancer. Patients with cancer had a higher burden of cardiovascular risk factors and pre-existing cardiac disease. Total length of stay in the ED (5.2 hours vs 4.3 hours) and hospitalization rate (49.8% vs 34.3%) were both increased in patients with cancer (P < 0.001 for both). Among 8,093 patients eligible for the AMI analyses, those with cancer more often had final diagnoses of AMI (184 of 686 with cancer [26.8%] vs 1,561 of 7,407 without cancer [21.1%]; P < 0.001). In patients with cancer, high-sensitivity cardiac troponin T (hs-cTnT) but not high sensitivity cardiac troponin I (hs-cTnI) concentration had lower diagnostic accuracy for non–ST-segment elevation myocardial infarction (for hs-cTnT, area under the curve: 0.89 [95% CI: 0.86-0.92] vs 0.94 [95% CI: 0.93-0.94] [P < 0.001]; for hs-cTnI, area under the curve: 0.93 [95% CI: 0.91-0.95] vs 0.95 [95% CI: 0.94-0.95] [P = 0.10]). In patients with cancer, the European Society of Cardiology 0/1-hour hs-cTnT and hs-cTnI algorithms maintained very high safety but had lower efficacy, with twice the number of patients remaining in the observe zone. Similar findings were obtained in the external validation cohort. CONCLUSIONS: Patients with cancer have a substantially higher prevalence of AMI as the cause of chest pain. Length of ED stay and hospitalization rates are increased. The diagnostic performance of hs-cTnT and the efficacy of both the European Society of Cardiology 0/1-hour hs-cTnT and hs-cTnI algorithms is reduced. (Advantageous Predictors of Acute Coronary Syndromes Evaluation [APACE] Study; NCT00470587)
format Online
Article
Text
id pubmed-10635894
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106358942023-11-15 Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins Bima, Paolo Lopez-Ayala, Pedro Koechlin, Luca Boeddinghaus, Jasper Nestelberger, Thomas Okamura, Bernhard Muench-Gerber, Tamar S. Sanzone, Alessandra Skolozubova, Daria Djurdjevic, David Rubini Gimenez, Maria Wildi, Karin Miro, Oscar Martínez-Nadal, Gemma Martin-Sanchez, Francisco J. Christ, Michael Keller, Dagmar Lindahl, Bertil Giannitsis, Evangelos Mueller, Christian JACC CardioOncol Original Research BACKGROUND: Little is known about patients with cancer presenting with acute chest discomfort to the emergency department (ED). OBJECTIVES: The aim of this study was to assess the prevalence of acute myocardial infarction (AMI), outcomes, and the diagnostic utility of recommended diagnostic tools in this population. METHODS: Patients presenting with chest pain to the ED were prospectively enrolled in an international multicenter diagnostic study with central adjudication. Cancer status was assessed prospectively and additional cancer details retrospectively. Findings were externally validated in an independent multicenter cohort. RESULTS: Among 8,267 patients, 711 (8.6%) had cancer. Patients with cancer had a higher burden of cardiovascular risk factors and pre-existing cardiac disease. Total length of stay in the ED (5.2 hours vs 4.3 hours) and hospitalization rate (49.8% vs 34.3%) were both increased in patients with cancer (P < 0.001 for both). Among 8,093 patients eligible for the AMI analyses, those with cancer more often had final diagnoses of AMI (184 of 686 with cancer [26.8%] vs 1,561 of 7,407 without cancer [21.1%]; P < 0.001). In patients with cancer, high-sensitivity cardiac troponin T (hs-cTnT) but not high sensitivity cardiac troponin I (hs-cTnI) concentration had lower diagnostic accuracy for non–ST-segment elevation myocardial infarction (for hs-cTnT, area under the curve: 0.89 [95% CI: 0.86-0.92] vs 0.94 [95% CI: 0.93-0.94] [P < 0.001]; for hs-cTnI, area under the curve: 0.93 [95% CI: 0.91-0.95] vs 0.95 [95% CI: 0.94-0.95] [P = 0.10]). In patients with cancer, the European Society of Cardiology 0/1-hour hs-cTnT and hs-cTnI algorithms maintained very high safety but had lower efficacy, with twice the number of patients remaining in the observe zone. Similar findings were obtained in the external validation cohort. CONCLUSIONS: Patients with cancer have a substantially higher prevalence of AMI as the cause of chest pain. Length of ED stay and hospitalization rates are increased. The diagnostic performance of hs-cTnT and the efficacy of both the European Society of Cardiology 0/1-hour hs-cTnT and hs-cTnI algorithms is reduced. (Advantageous Predictors of Acute Coronary Syndromes Evaluation [APACE] Study; NCT00470587) Elsevier 2023-08-26 /pmc/articles/PMC10635894/ /pubmed/37969646 http://dx.doi.org/10.1016/j.jaccao.2023.08.001 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Bima, Paolo
Lopez-Ayala, Pedro
Koechlin, Luca
Boeddinghaus, Jasper
Nestelberger, Thomas
Okamura, Bernhard
Muench-Gerber, Tamar S.
Sanzone, Alessandra
Skolozubova, Daria
Djurdjevic, David
Rubini Gimenez, Maria
Wildi, Karin
Miro, Oscar
Martínez-Nadal, Gemma
Martin-Sanchez, Francisco J.
Christ, Michael
Keller, Dagmar
Lindahl, Bertil
Giannitsis, Evangelos
Mueller, Christian
Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins
title Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins
title_full Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins
title_fullStr Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins
title_full_unstemmed Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins
title_short Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins
title_sort chest pain in cancer patients: prevalence of myocardial infarction and performance of high-sensitivity cardiac troponins
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635894/
https://www.ncbi.nlm.nih.gov/pubmed/37969646
http://dx.doi.org/10.1016/j.jaccao.2023.08.001
work_keys_str_mv AT bimapaolo chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT lopezayalapedro chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT koechlinluca chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT boeddinghausjasper chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT nestelbergerthomas chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT okamurabernhard chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT muenchgerbertamars chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT sanzonealessandra chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT skolozubovadaria chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT djurdjevicdavid chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT rubinigimenezmaria chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT wildikarin chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT mirooscar chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT martineznadalgemma chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT martinsanchezfranciscoj chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT christmichael chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT kellerdagmar chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT lindahlbertil chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT giannitsisevangelos chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT muellerchristian chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins
AT chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins